Total Visits

Views
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database83

Select a period of time:

Views

Views
October 20258
November 20251
December 20252
January 202612
February 20260
March 20265
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Finland5
Brazil3
United Kingdom2
Argentina1
Australia1
Colombia1
Ethiopia1
Mexico1
Tunisia1
 

Top cities views

Views
Helsinki5
Council Bluffs2
Addis Ababa1
Arapiraca1
Celaya1
Fair Oaks1
Johannesburg1
Kansas City1
Los Angeles1
Mar del Plata1